Uz M, Bulmus V, Alsoy Altinkaya S
ACS Omega. 2024; 9(48):47461-47474.
PMID: 39651078
PMC: 11618417.
DOI: 10.1021/acsomega.4c05808.
Aundhia C, Shah N, Talele C, Zanwar A, Kumari M, Patil S
Pharm Nanotechnol. 2024; 13(1):55-69.
PMID: 38284710
DOI: 10.2174/0122117385271654231215064542.
Jagrosse M, Baliga U, Jones C, Russell J, Garcia C, Najar R
Mol Pharm. 2023; 20(12):6090-6103.
PMID: 37963105
PMC: 10698724.
DOI: 10.1021/acs.molpharmaceut.3c00455.
Liu M, Xu L, Jiang J, Dong H, Zhu P, Cao L
Bioeng Transl Med. 2023; 8(5):e10558.
PMID: 37693059
PMC: 10486340.
DOI: 10.1002/btm2.10558.
Dzhuzha A, Gandalipov E, Korzhikov-Vlakh V, Katernyuk E, Zakharova N, Silonov S
Pharmaceutics. 2023; 15(4).
PMID: 37111793
PMC: 10143851.
DOI: 10.3390/pharmaceutics15041308.
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide.
Nakamura M, Fujiwara K, Doi N
J Nanobiotechnology. 2022; 20(1):458.
PMID: 36303212
PMC: 9615171.
DOI: 10.1186/s12951-022-01667-4.
Investigation of the ionic conditions in SiRNA-mediated delivery through its carriers in the cell membrane: a molecular dynamic simulation.
Darvishi M, Allahverdi A, Hashemzadeh H, Javadi H
Sci Rep. 2022; 12(1):17520.
PMID: 36266467
PMC: 9582388.
DOI: 10.1038/s41598-022-22509-1.
Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease.
Shinn J, Lee J, Lee S, Lee S, Choi A, Kim J
Pharmaceutics. 2022; 14(9).
PMID: 36145716
PMC: 9503894.
DOI: 10.3390/pharmaceutics14091969.
VEGF Overexpression Significantly Increases Nanoparticle-Mediated siRNA Delivery and Target-Gene Downregulation.
Tan S, Chen Z, Mironchik Y, Mori N, Penet M, Si G
Pharmaceutics. 2022; 14(6).
PMID: 35745832
PMC: 9229257.
DOI: 10.3390/pharmaceutics14061260.
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug.
de Brito E Cunha D, Frederico A, Azamor T, Melgaco J, Neves P, Ano Bom A
Pharmaceuticals (Basel). 2022; 15(5).
PMID: 35631401
PMC: 9146980.
DOI: 10.3390/ph15050575.
pH-sensitive zwitterionic polycarboxybetaine as a potential non-viral vector for small interfering RNA delivery.
Peng H, Ji W, Zhao R, Lu Z, Yang J, Li Y
RSC Adv. 2022; 10(73):45059-45066.
PMID: 35516239
PMC: 9058814.
DOI: 10.1039/d0ra09359a.
RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics.
Pandey P, Young K, Kumar D, Jain N
Mol Cancer. 2022; 21(1):58.
PMID: 35189921
PMC: 8860277.
DOI: 10.1186/s12943-022-01528-6.
Specific Silencing of Microglial Gene Expression in the Rat Brain by Nanoparticle-Based Small Interfering RNA Delivery.
Guo S, Cazarez-Marquez F, Jiao H, Foppen E, Korpel N, Grootemaat A
ACS Appl Mater Interfaces. 2022; 14(4):5066-5079.
PMID: 35041392
PMC: 8815040.
DOI: 10.1021/acsami.1c22434.
Induced Pluripotent Stem Cells (iPSCs) and Gene Therapy: A New Era for the Treatment of Neurological Diseases.
Paolini Sguazzi G, Muto V, Tartaglia M, Bertini E, Compagnucci C
Int J Mol Sci. 2021; 22(24).
PMID: 34948465
PMC: 8706293.
DOI: 10.3390/ijms222413674.
Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
Oh-Hohenhorst S, Lange T
Cancers (Basel). 2021; 13(17).
PMID: 34503302
PMC: 8431208.
DOI: 10.3390/cancers13174492.
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi Y, Qi W, Xia B, Lou G, Jin W
Front Immunol. 2021; 12:697083.
PMID: 34295338
PMC: 8290853.
DOI: 10.3389/fimmu.2021.697083.
A Simple and Quick Method for Loading Proteins in Extracellular Vesicles.
Busatto S, Iannotta D, Walker S, Di Marzio L, Wolfram J
Pharmaceuticals (Basel). 2021; 14(4).
PMID: 33924377
PMC: 8069621.
DOI: 10.3390/ph14040356.
A small interfering RNA (siRNA) database for SARS-CoV-2.
Gomes Medeiros I, Khayat A, Stransky B, Santos S, Assumpcao P, de Souza J
Sci Rep. 2021; 11(1):8849.
PMID: 33893357
PMC: 8065152.
DOI: 10.1038/s41598-021-88310-8.
miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.
Arrighetti N, Beretta G
Pharmaceutics. 2021; 13(3).
PMID: 33805590
PMC: 7999286.
DOI: 10.3390/pharmaceutics13030380.
Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.
Yamada Y, Sato Y, Nakamura T, Harashima H
J Control Release. 2020; 327:533-545.
PMID: 32916227
PMC: 7477636.
DOI: 10.1016/j.jconrel.2020.09.007.